Burzynski Research Institute, Inc. (BZYR)

OTCMKTS · Delayed Price · Currency is USD
0.0360
0.00 (0.00%)
Apr 25, 2025, 4:00 PM EDT
-13.83%
Market Cap 4.77M
Revenue (ttm) n/a
Net Income (ttm) -1.46M
Shares Out 131.45M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 29,930
Average Volume 3,280
Open 0.0355
Previous Close 0.0360
Day's Range 0.0350 - 0.0360
52-Week Range 0.0300 - 0.0770
Beta 1.68
RSI 39.33
Earnings Date May 27, 2025

About BZYR

Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs for the treatment of various cancers. The company is involved in the research, production, marketing, promotion, and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids under the Antineoplastons trade name. It also offers consulting services. The company was incorporated in 1984 and is headquartered in Houston, Texas. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1984
Employees 1
Stock Exchange OTCMKTS
Ticker Symbol BZYR
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.